MA
Michael F Adams
CEODirector

Michael F Adams insider trades: AdvanSource Biomaterials (ASNB) stock purchases

CEO, AdvanSource Biomaterials Last trade Aug 23, 2017 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
21
Open-market trades
since 2012
4
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

21 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 23, 2017ASNB↑ Buy$800
Aug 21, 2017ASNB↑ Buy$650
Nov 30, 2015ASNB↑ Buy$1K
Aug 20, 2015ASNB↑ Buy$633
Aug 19, 2015ASNB↑ Buy$1K
Aug 19, 2015ASNB↑ Buy$316
Aug 19, 2015ASNB↑ Buy$250
Aug 18, 2015ASNB↑ Buy$10K
Dec 13, 2013ASNB↑ Buy$600
Dec 10, 2013ASNB↑ Buy$725
Dec 9, 2013ASNB↑ Buy$1K
Dec 4, 2013ASNB↑ Buy$880
Sep 6, 2013ASNB↑ Buy$2K
Dec 14, 2012ASNB↑ Buy$2K
Dec 10, 2012ASNB↑ Buy$200
Dec 6, 2012ASNB↑ Buy$640
Dec 4, 2012ASNB↑ Buy$850
Dec 3, 2012ASNB↑ Buy$247
Nov 27, 2012ASNB↑ Buy$269
Nov 20, 2012ASNB↑ Buy$1K
Sep 14, 2012ASNB↑ Buy$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael F Adams's insider trades

Michael F Adams is CEO at AdvanSource Biomaterials (ASNB). Since Sep 14, 2012, Michael has reported 21 open-market purchases worth $27K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), other transactions (7 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ASNB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.